Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MYRIAD GENETICS INC | Director | Common Stock | 32.9K | $726K | $22.05 | Jun 6, 2024 | Direct |
vTv Therapeutics Inc. | Director | Director stock option (right to buy) | 6K | $103K | $17.22 | Jun 25, 2024 | Direct |
SPRUCE BIOSCIENCES, INC. | Director | Stock Option (Right to Buy) | 30K | May 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VTVT | vTv Therapeutics Inc. | Jun 25, 2024 | 1 | $103K | 4 | Jun 27, 2024 | Director |
VTVT | vTv Therapeutics Inc. | Jun 11, 2024 | 0 | $0 | 3 | Jun 13, 2024 | Director |
MYGN | MYRIAD GENETICS INC | Jun 6, 2024 | 0 | $0 | 4 | Jun 7, 2024 | Director |
MYGN | MYRIAD GENETICS INC | Jun 3, 2024 | 2 | -$167K | 4 | Jun 4, 2024 | Director |
SPRB | SPRUCE BIOSCIENCES, INC. | May 22, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
KYTX | Kyverna Therapeutics, Inc. | Feb 7, 2024 | 0 | $0 | 3 | Feb 7, 2024 | Director |
MYGN | MYRIAD GENETICS INC | Jun 1, 2023 | 2 | -$199K | 4 | Jun 2, 2023 | Director |
SPRB | SPRUCE BIOSCIENCES, INC. | May 25, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
MYGN | MYRIAD GENETICS INC | Jun 6, 2022 | 1 | -$124K | 4 | Jun 6, 2022 | Director |
MYGN | MYRIAD GENETICS INC | Jun 2, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
SPRB | SPRUCE BIOSCIENCES, INC. | May 25, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
MYGN | MYRIAD GENETICS INC | Jun 17, 2021 | 1 | -$95.8K | 4 | Jun 17, 2021 | Director |
MYGN | MYRIAD GENETICS INC | Jun 3, 2021 | 1 | $0 | 4 | Jun 4, 2021 | Director |
MYGN | MYRIAD GENETICS INC | May 28, 2021 | 1 | -$207K | 4 | Jun 1, 2021 | Director |
MYGN | MYRIAD GENETICS INC | May 27, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |
SPRB | SPRUCE BIOSCIENCES, INC. | May 20, 2021 | 1 | $0 | 4 | May 21, 2021 | Director |